4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001415889-25-021066
Director bought 1,300,000 shares at an average $10.45 ($13,590,000)
From the SEC's structured data for this filing
Trades in this filing
TANG KEVIN · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-01 | Purchase : show line 1 in the form | +1,000,000 | $10.12 | $10,120,000 | 11,029,500 | I |
| 2025-08-04 | Purchase : show line 2 in the form | +100,000 | $11.34 | $1,134,000 | 11,129,500 | I |
| 2025-08-05 | Purchase : show line 3 in the form | +200,000 | $11.68 | $2,336,000 | 11,329,500 | I |
| Open-market purchases · 1,300,000 sh · avg $10.45 · $13,590,000 | ||||||
Loading xslF345X05/form4-08052025_090800.xml…